Prize

........... Recipient of the 2010 MacDougal Irving Prize for Truth in Market Manipulation ...........

January 21, 2014

The Elephant in the Room


         One source defines the healthcare sector as “a category of stocks relating to medical and healthcare goods or services,” including “hospital management firms, health maintenance organizations (HMOs), biotechnology and a variety of medical products”.  Insurance providers, health care real estate investment trusts, and medical equipment manufacturers are three industries warranting specific mention, and it should be noted that pharmaceutical companies generally dominate the holdings of health care mutual funds.

         Lately, anytime we start pondering investment decisions in this arena, Obamacare stops us dead.  This abomination is an insurance plan right now, but how will nationalization impact the rest of the healthcare sector once their antiestablishment ball gains momentum?  Tackling insurance benefits suggests across-the-board price control to us.  That places everything from Band-Aids to physician compensation on the table, and all seem likely to be targeted by a proven pack of fools who have no idea what they’re dealing with.

         Remember, this is a President with absolutely zero business experience who drew 92% of his closest advisors, by one apparently reliable count anyway, from outside the business world.

         A cursory review of what’s next with government intervention into healthcare indicates that nobody knows what’s next.  The silence is deafening.

         Clearly, this is not a future our subscribers should be invested in.

         Time and time again, we keep coming up with the same conclusion.  Hold large cap multinationals.  Especially in this particular sector, now is no time to be buying American.